Product
LY03017-Placebo
1 clinical trial
3 indications
Indication
Alzheimer's Disease PsychosisIndication
SchizophreniaClinical trial
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, SAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Oral LPM526000133 Fumarate Capsules (LY03017) in Healthy Adult Subjects.Status: Not yet recruiting, Estimated PCD: 2025-03-30